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Neuropathic pain is a widespread chronic pain state
that results from injury to the nervous system. Spinal
microglia play a causative role in the pathogenesis of
neuropathic pain through secretion of growth factors
and cytokines. Here, we investigated the contribu-
tion of TMEM16F, a protein that functions as a
Ca2+-dependent ion channel and a phospholipid
scramblase, to microglial activity during neuropathic
pain. We demonstrate that mice with a conditional
ablation of TMEM16F in microglia do not develop
mechanical hypersensitivity upon nerve injury. In
the absence of TMEM16F, microglia display deficits
in process motility and phagocytosis. Moreover,
loss of GABA immunoreactivity upon injury is spared
in TMEM16F conditional knockout mice. Collectively,
these data indicate that TMEM16F is an essential
component of the microglial response to injury and
suggest the importance of microglial phagocytosis
in the pathogenesis of neuropathic pain.INTRODUCTION
Neuropathic pain is a widespread and debilitating clinical condi-
tion that is triggered by a lesion in the nervous system. (Campbell
and Meyer, 2006; Costigan et al., 2009). It is becoming increas-
ingly apparent that spinal microglia play a causative role in the
pathogenesis of neuropathic pain (Scholz and Woolf, 2007). Pe-
ripheral nerve injury is associated with a pronounced recruitment
of microglia to the spinal cord, and a conversion of these cells
into a reactive state (Gehrmann et al., 1991), whereby they in-
crease synthesis and release of bioactive molecules (Clark
et al., 2007, 2013).
The most characterized mechanism through which microglia
contribute to neuropathic pain involves a molecular pathway2608 Cell Reports 15, 2608–2615, June 21, 2016 ª 2016 The Authors
This is an open access article under the CC BY license (http://creativethat is dependent upon upregulation of microglial purinergic
P2X4 receptors (Beggs et al., 2012; Tsuda et al., 2003) and
increased release of brain-derived neurotrophic factor (BDNF)
from microglia, which acts on dorsal horn lamina I neurons to
shift their transmembrane anion gradient (Coull et al., 2003,
2005). As a result, inhibitory synaptic signaling through GABAA
and glycine receptors is diminished. Furthermore, loss of inhibi-
tion is exacerbated by reduced production and release of spinal
GABA (Lever et al., 2003; Moore et al., 2002) and injury-induced
loss of GABAergic interneurons in the dorsal horn (Scholz et al.,
2005; Sugimoto et al., 1990).
Microglia also have awell-established role in the detection and
removal of apoptotic neuronal material (Davalos et al., 2005; Fu
et al., 2014; Sierra et al., 2013). Upon injury, activated microglia
converge on the dorsal horn in response to chemokine and ATP
signaling and survey and modify sensory afferent input for dam-
age via probing and extension of their processes (Davalos et al.,
2005). Critical to this function is the activation of ion channels,
which, through modulation of membrane potential, cell volume,
and ion concentration promotes themovement of microglial pro-
cesses and the initiation of phagocytosis. However, it is not
known whether these mechanisms are important for aberrant
nociceptive processing under pathological pain conditions.
Recently, a family of ion channels has been identified
belonging to the TMEM16 family of proteins, which display func-
tional diversity and may contribute to microglial function. The
founding member of this family TMEM16A acts as a Ca2+-acti-
vated Cl channel (Caputo et al., 2008; Schroeder et al., 2008;
Yang et al., 2008), and another member TMEM16F has been pro-
posed to be a Ca2+-dependent phospholipid scramblase (Suzuki
et al., 2010), and a Ca2+-activated channel with either anion (Al-
mac¸a et al., 2009; Martins et al., 2011; Tian et al., 2012) or non-
selective cation (Yang et al., 2012) permeability. Each of these
molecular mechanisms could contribute to spinal microglial
function in neuropathic pain states.
To investigate whether TMEM16 channels play a role in neuro-
pathic pain, we assayed the expression levels of all TMEM16
family members in microglia and observed high enrichment of.
commons.org/licenses/by/4.0/).
Figure 1. TMEM16 Expression and Generation of Conditional TMEM16F Knockout Mice
(A) RT-PCR analysis of TMEM16 transcripts in microglia, dorsal root ganglia (DRGs), kidney, and brain; p < 0.0001; n = 3.
(B) Representative images of injured sciatic nerve from indicated genotypes, 7 days after injury.
(C) Iba1 (green) and RFP (red) immunofluorescence in the lumbar spinal cord LysMCre/Rosa26tdRFP mouse, 3 days after injury.
(D) Iba1 (green) and RFP (red) immunofluorescence of microglia in the hippocampus from LysMCre/Rosa26tdRFP mouse.
(E) In situ hybridization for TMEM16F (red) and Iba1 (green) immunofluorescence of microglia in spinal cord, 7 days after injury.
(F) High-magnification representative images of TMEM16F in situ hybridization in control and cKO mice.
(G) In situ hybridization for TMEM16F in peritoneal macrophages cells from control and cKO mice.
Values are mean ± SEM. Scale bars, 100 and 40 mm (B), 100 mm (C), 20 mm (D, F, and G), 300 mm (E). See also Figure S1.TMEM16F transcript. We thus generated a conditional knockout
mouse line in which TMEM16F is genetically ablated in cells
of the myeloid lineage. We demonstrate that, in the absence
of TMEM16F, microglia are dysmorphic and exhibit deficits
in process motility and phagocytosis. Moreover, TMEM16F con-
ditional knockout mice display a pronounced reduction in me-
chanical hypersensitivity after peripheral nerve injury, suggesting
that the classical scavenger function of microglia could be a fac-
tor in the pathogenesis of neuropathic pain.
RESULTS
TMEM16 Expression Profiling and Generation of a
TMEM16F Conditional Knockout Mouse Line
In order to identify TMEM16 proteins with a potential role in
pain processing, we performed expression profiling of all ten
TMEM16 familymembers in dorsal root ganglia (DRG), microglia,
and brain and compared their relative expression to basal levels
in kidney using qRT-PCR. We observed a strikingly high expres-
sion of TMEM16F in microglia that was not apparent in other tis-sues tested (Figure 1A). Moreover, TMEM16F is the predominant
microglial TMEM16 transcript with levels 4-fold higher than the
next highest transcript TMEM16J.
To investigate the significance of the high expression of
TMEM16F in microglia, we generated conditional TMEM16F
knockout mice (Figure S1A). We tested two separate Cre driver
lines, CX3CR1Cre (Yona et al., 2013) and LysMCre (Clausen et al.,
1999), crossed with Cre-dependent reporter lines for selective
microglial and macrophage recombination. As previously re-
ported (Eriksson et al., 1993), we observed substantial micro-
gliosis in ipsilateral spinal cord upon injury. However, in
CX3CR1Cre::Rosa26tdRFP mice, reporter expression was evident
in both microglia and neurons throughout the spinal cord (Fig-
ureS1E). In contrast,LysMCre::Rosa26tdRFPmicedisplayedselec-
tive expression in macrophages recruited to the injury site, and in
microglia in the spinal cord and brain (Figures 1B–1D). In situ hy-
bridization for TMEM16F and immunostaining for microglial
marker Iba1 in spinal cord sections from injured mice, confirmed
robust TMEM16F expression in spinal microglia from LysMCre::
TMEM16Ffl/+ mice and a decrease in TMEM16F mRNA inCell Reports 15, 2608–2615, June 21, 2016 2609
Figure 2. Microglial TMEM16F Is Required for the Development of Mechanical Hypersensitivity in the PNL Neuropathic Pain Model
(A) Paw withdrawal thresholds of TMEM16Ffl/fl (control) and LysMcre/TMEM16Ffl/fl (cKO)mice showing ipsilateral (ipsi) and contralateral (contra) paw withdrawals
before and after partial nerve ligation (PNL). n = 9; p < 0.05.
(B) From left to right: microglial Iba1 immunofluorescence in the lumbar spinal cord after injury (left side), magnified images from control and cKO tissues 2 days
after PNL. Bar graphs show microglial densities in injured (PNL) and non-injured (sham) tissue 2 (left) and 7 (right) days after injury. n = 8/9; p < 0.05.
(C) Neuronal marker NeuN immunofluorescence in the ipsilateral dorsal horn from control (top) and cKO (bottom) mice; bar graph showing neuronal density in the
imaged volume. n = 10/7; p < 0.05.
(D) CD68 (red) and Iba1 (green) immunofluorescence in the ipsilateral dorsal horn from control and cKOmice. CD68 immunoreactivity in Iba1 positive cells at 2 and
7 days after injury. n = 6; p < 0.01.
(E) Top: Iba1 (red) and DAPI (blue) immunolabeling in the ipsilateral dorsal horn; 3D image segmentation using IMARIS Bitplane surface (middle) and filament
(bottom) algorithms.
(F) Frequency distribution of microglial volume in the ipsilateral dorsal horn from control and cKO mice, n = 79/277 cells; p = 0.005.
(G) Frequency distribution of microglial total branch length in the ipsilateral dorsal horn from control and cKO mice; p = 0.0293.
Values are mean ± SEM. Scale bars represent 100 mm (B), 30 mm (C), 20 mm (D), 40 mm, and 7 mm (E). See also Figures S2 and S3.microglia and macrophages from LysMCre::TMEM16Ffl/fl mice
(Figures 1E–1G). We thus performed all further analysis on
the LysMCre:: TMEM16Ffl/fl (cKO) line using TMEM16Ffl/fl (in the
absence of Cre) or LysMCre:: TMEM16Ffll+ mice as controls.
Microglial TMEM16F Is Required for Neuropathic Pain
Development
To determine whether TMEM16F contributes to microglial
function in pain states, we monitored nociceptive behavior in
LysMCre::TMEM16Ffl/fl mice in models of neuropathic and inflam-
matory pain. In control mice subjected to partial nerve ligation
(PNL), we observed a pronounced mechanical allodynia that
peaked at 7 days post-injury. Strikingly, deletion of TMEM16F in
microglia andmacrophagesprevented thedevelopment ofallody-
nia, and mechanical withdrawal thresholds remained at pre-injury
levels throughout the monitoring period (Figure 2A), an effect that
was observed in both male and female mice (Figure S2A).
To investigate thecontributionofmicroglial TMEM16F to inflam-
matory pain, we used the Complete Freund’s Adjuvant (CFA)
model. We observed mechanical allodynia 48 hr after intraplantar
injection of CFA in control animals. In contrast to the PNL model,
LysMCre::TMEM16Ffl/flmicedevelopedmechanical hypersensitiv-
ity to the same extent as litter mate controls (Figure S2B).
To explore whether TMEM16F contributes to proliferative,
migratory, and phagocytic responses of microglia upon periph-
eral nerve injury, we performed quantitative image analysis on2610 Cell Reports 15, 2608–2615, June 21, 2016immunohistologically labeled spinal cord sections. Intriguingly,
the total number of Iba1 positive microglia increased more
rapidly after injury in lumbar spinal cords from LysMCre::
TMEM16Ffl/fl compared to control mice, and 3 days post-injury
this had already reached maximal levels. In contrast, microglial
density from control mice required 7 days to reach similar levels
(Figure 2B).We observed no difference in the number of neuronal
cell bodies in at seven days post-injury between control and con-
ditional knockout (cKO) animals (Figure 2C).
We investigated the activation status of microglia by quanti-
fying lysosomal protein CD68 immunoreactivity (Holness and
Simmons, 1993) in Iba1 positive cells and observed a dramatic
increase at 2 days post-injury in control spinal cords that had
normalized to baseline levels 7 days post-injury. In contrast, in
spinal cords from LysMCre::TMEM16Ffl/fl mice, CD68 immunore-
activity was significantly reduced compared to control (Fig-
ure 2D), suggesting that microglial phagocytic activity was
impaired in the absence of TMEM16F.
We further examined morphological characteristics of spinal
microglia, using 3D reconstruction of spinal cord confocal stacks
and segmentation of Iba1 positive cells (Figure 2E). Microglia
were significantly smaller in size and less branched in the ipsilat-
eral dorsal horn of cKO mice compared to controls (Figures 2F
and 2G).
As an additional measure of microglial function, we performed
immunostaining for P2X4 receptors. Upon PNL, there was an
Figure 3. Histological and Biochemical Analysis of Macrophages
Recruited at the Nerve Injury
(A) Iba1 (red), CD68 (green), and DAPI (blue) immunofluorescence in the ipsi-
lateral nerve cryosections from control and cKOmice, 7 days after injury. Scale
bar, 20 mm.
(B) Density of Iba1 positive macrophages at the distal side of the nerve injury at
3 and 7 days after injury. n = 3, p < 0.05.
(C) Size of Iba1 positive macrophages on the distal side of the nerve injury at 3
and 7 days after injury; n = 3; p < 0.05.
(D) CD68 intensity in Iba1 positive macrophages, 7 days after PNL; n = 3;
p > 0.05.
(E) Cytokine/chemokine array blots incubated with contralateral and ipsi-
lateral sciatic nerve extracts (130 mg) from control and cKO mice, 4 days after
injury.increase in P2X4 staining in the ipsilateral side compared to
contralateral (73% ± 16%), also observed in the cKO mice
(92% ± 17%; Figure S3).
To determine whether genetic ablation of TMEM16F perturbed
the function of macrophages in the PNL model, we assessed
macrophage recruitment, morphology, and activation at the
nerve injury site (Figure 3A). In contrast to data from microglia,
we observed no significant difference in the number (Figure 3B),
size (Figure 3C), or CD68 immunoreactivity (Figure 3D) of macro-
phages in cKOmice compared to controls. Moreover, release of
pro-inflammatory cytokines and chemokines upon nerve injury
was also not significantly changed in LysMCre::TMEM16Ffl/fl
mice (Figures 3E–3G). Thus, TMEM16F may play a more promi-
nent role in microglia compared to peripheral macrophages in
the PNL model of neuropathic pain.
TMEM16F Influences Microglia Motility and Engulfment
of Neuronal Material
We developed an ex vivo preparation for live imaging of
microglia, using a triple transgenic CX3CR1GFP:: LysMCre::
TMEM16Ffl/fl, in which GFP is robustly expressed in microglia.
We examined microglial branch extension in hippocampal sli-
ces by applying an ATP puff through a glass micropipette to
mimic ATP release from damaged neurons (Davalos et al.,
2005). Strikingly, the directed movement of microglia branches
was significantly reduced in hippocampal slices from cKOGFP
compared to ControlGFP mice (Figure 4A; Movie S1). Using
tracking analysis of single microglial branches, we observed
that the mean elongation velocity of single tracks after an ATP
puff was significantly reduced in cKOGFP (1.11 ± 0.03 mm/min)
compared to ControlGFP mice (1.28 ± 0.06 mm/min; p = 0.017, t
test).
As an additional marker of peripheral sensory input into the
spinal cord, Cholera Toxin B (CTB)-Alexa 647 was injected intra-
neurally into the sciatic nerve when performing PNL surgery.
During live imaging from spinal cord slices, microglia from
cKOGFP mice displayed significantly reduced motility (Figure 4B;
Movie S2). Strikingly, we observed that the engulfment of CTB-
Alexa-647-labeled nerve terminals was reduced in cKOGFP
compared to ControlGFP mice (Figure 4C; Movie S3).
In agreement with observations from ex vivo spinal cord
preparations, isolated microglia from Rosa26Clsensor::LysMCre::
TMEM16Ffl/fl (cKOClsensor) mice displayed reduced phagocy-
tosis of fluorescently labeled yeast, compared to control
Rosa26Clsensor:: LysMCre::TMEM16Ffl/+ (1.6 ± 0.2, n = 96 for
control versus 0.9 ± 0.1, n = 87 for cKO, p < 0.05, t test, at
30 min) (Movie S4).
What is the link between impairedmicroglial phagocytosis and
reduced neuropathic pain in TMEM16F cKO mice? Intriguingly,
sciatic nerve injury has previously been associated with a(F) Pixel densities of selected cytokine spots in the contralateral and ipsilateral
sciatic nerve lysates from control mice. p < 0.05, p < 0.01. n = 3 sets of pooled
samples from four mice each.
(G) Pixel densities of selected cytokine spots in the ipsilateral sciatic nerve
lysates from control and cKO mice 4 days after injury, p > 0.05.
Values are mean ± SEM.
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Figure 4. TMEM16F Regulates Microglia Branch Motility and Engulfment of Neuronal Material
(A) Top: fluorescence changes in a ControlGFP hippocampal slice near the tip (green squares). Bottom: relative fluorescence increase measured in a 10-mm radius
from the ATP-containing (3 mM) pipette in acute hippocampal slices frommice of indicated genotypes, n = 9/24 fields in three of seven mice; p < 0.05 from 25 to
34 min.
(B) Top: ipsilateral dorsal horn sections from mice of indicated genotypes. The selected segmented GFP positive microglia (yellow) is surrounded by a bounding
box (red), whichwas used for branchmotility analysis. Bottom: SD of the bounding box from its mean value over time to quantify microglia branchmotility in spinal
cord slices, from mice of indicated genotypes.; n = 44/45 cells; p < 0.0001.
(C) Segmentation of GFP positive microglia (green) and Alexa-647-labeled neurons, external to microglia (blue) and internalized (pink). Ratio of internalized over
total labeled neuronal material to quantify engulfed neuronal terminals by microglia over time.
(D) Top: image segmentation: GABA positive neuron (red) colocalizes (white) within Iba1 positive microglia (green) after injury. Bottom: Iba1 (green) and GABA
(red) immunofluorescence in the ipsilateral and contralateral dorsal horns from control and cKOmice, 3 days after injury, with zoomed images from lamina I–III in
the insets.
(E) Density of GABA-positive neurons in the lamina I–III of the dorsal horn of control and cKO mice, 3 days after injury. p < 0.05, n = 5.
Values are mean ± SEM. Scale bar, 50 mm (B and C) and 60 mm (D). See Movies S1, S2, S3, and S4.selective loss of GABA in the ipsilateral dorsal horn, which, in
turn, reduces inhibitory control in the spinal cord and promotes
mechanical hypersensitivity (Scholz et al., 2005; Sugimoto
et al., 1990). We therefore asked whether loss of GABA might
be spared in TMEM16F cKO mice, perhaps as a consequence
of the diminished phagocytic capacity of microglia. Utilizing
immunohistochemistry for GABA in lumbar spinal cord sections,
we observed a significant reduction in GABA staining in the
ipsilateral dorsal horn of control mice upon injury (Figure 4D).
Strikingly, in TMEM16F knockout mice this reduction was not
apparent, and ipsilateral and contralateral sides displayed
similar numbers of GABA positive neuron (Figure 4E).2612 Cell Reports 15, 2608–2615, June 21, 2016DISCUSSION
In this study, we explored the significance of high expression
levels of TMEM16F in microglia via conditional ablation of the
TMEM16F gene in cells of the myeloid lineage. We demonstrate
that TMEM16F conditional knockout mice do not develop me-
chanical hypersensitivity after peripheral nerve injury and that
this is associated with a reduced phagocytosis by spinal micro-
glia. Moreover, in both in vivo and ex vivo preparations, microglia
exhibit deficits in function that is reflected in their altered
morphology, expression of activation markers, and diminished
branch motility and phagocytic capacity. Together our data
suggest that that the phagocytic activity of microglia is an impor-
tant component in the cascade of events that lead to altered
nociceptive processing in neuropathic pain.
We opted for a conditional genetic strategy to delete
TMEM16F and after assessing two Cre driver lines (Clausen
et al., 1999; Yona et al., 2013) for reporter gene expression,
selected LysMCre as this drove expression specifically in micro-
glia in the spinal cord. However, Cre-mediated recombination
was not evident in all microglia. We addressed this issue in
in vitro studies by using triple transgenic mice expressing Cre-
dependent reporter and only selecting fluorescent cells for anal-
ysis. In in vivo and ex vivo studies, however, the incomplete dele-
tion of TMEM16F from all microglia will presumably lead to an
underestimation of phenotypes. A further complication arising
from use of the LysMCre driver lines is that recombination will
also occur in macrophages. We observed no differences in
macrophage number, morphology, or activation at the injury
site in the sciatic nerve in cKO versus control mice, or in the
expression of inflammatory mediators in the injured nerve. More-
over, in the CFA inflammatory pain model, which does not pro-
voke microglial activation (Li et al., 2013; Lin et al., 2007), noci-
ceptive thresholds were similar between genotypes. These
data imply that TMEM16F has a more prominent role in microglia
than macrophages in neuropathic pain models. The further
development of Cre-driver lines, which selectively target micro-
glia with high efficiency, for example, inducibleCx3cr1CreERmice
(Parkhurst et al., 2013), will allow for a more direct assessment of
these issues.
Upon peripheral nerve injury, microglia migrate to the spinal
cord, proliferate, and assume an activated state (Gehrmann
et al., 1991; Guan et al., 2016). This is accompanied by an in-
crease in P2X4 receptor expression, release of BDNF, and disin-
hibition of lamina I neurons (Coull et al., 2003, 2005). We there-
fore asked whether deletion of TMEM16F in microglia would
impact upon any of these mechanisms. We observed no
decrease in microglial recruitment to the spinal cord (indeed
this was significantly increased in TMEM16F cKOmice), and up-
regulation of P2X4 receptor immunoreactivity in the ipsilateral
dorsal horn of TMEM16F cKO mice at levels similar to that
seen in control mice.
Other factors have also been demonstrated to contribute to a
loss of inhibition in the spinal cord, including a decrease in GABA
production and release, and degeneration of GABAergic inter-
neurons (Bra´z et al., 2012; Moore et al., 2002; Scholz et al.,
2005; Sugimoto et al., 1990). Intriguingly, we observed a reduc-
tion inGABA immunoreactivity in lamina I–III of the ipsilateral dor-
sal horn of control mice, which was absent in the cKO mice.
Together with our data on the impaired phagocytic capacity of
TMEM16F cKO microglia, we speculate that diminished phago-
cytosis may spare GABA loss and thus reduce disinhibition and
the development of mechanical hypersensitivity. This mecha-
nism could occur independently of complete loss of inhibitory
neurons by necrosis or apoptosis and instead happen via selec-
tive pruning of GABAergic terminals. Indeed, recent work by Pe-
titjean et al. (2015) has demonstrated that parvalbumin-positive
interneurons do not die after peripheral nerve injury but exhibit
reduced connectivity with PKCg neurons in the dorsal horn.
Thus, in addition to the well-established role of microglia inreleasing bioactive factors (Clark et al., 2007, 2013), their clas-
sical phagocytosis functionmay also contribute to the pathogen-
esis of neuropathic pain. Further investigation of the integrity of
spinal pain circuitry in TMEM16F cKO mice, as well as its role
in other cell types (Jiang et al., 2016; Sorge et al., 2015), will
shed more light on this issue.
TMEM16F functions as both a calcium dependent ion channel
and a phospholipid scramblase. Therefore, an important ques-
tion that arises from our data is whether deficits in microglial
phagocytosis are caused by alterations in ion transport or in
phosphatidylserine exposure in cKO cells. Intriguingly, both pro-
cesses have previously been shown to be important for phago-
cytosis and ramification in macrophages and microglia suggest-
ing that TMEM16F could utilize multiple mechanisms to
modulate microglial function (Callahan et al., 2000; Eder et al.,
1998). Recently, TMEM16F was also demonstrated to act down-
stream of P2X7 receptors and influence immune defense by
macrophages (Ousingsawat et al., 2015). While we observed
no deficits in macrophage function upon nerve injury in
TMEM16F knockout mice, other purinergic receptors such as
P2Y12 receptors have been implicated in microglial phagocy-
tosis. Indeed, P2Y12 is expressed exclusively by microglia
(Hickman et al., 2013; Kobayashi et al., 2011) and has been
demonstrated to play a key role in ATP-mediated branch rear-
rangement and phagocytosis of injured axons (Haynes et al.,
2006; Maeda et al., 2010; Ohsawa et al., 2010). Investigation of
interactions between TMEM16F and P2Y12 could therefore be
a useful starting point for developing therapeutic strategies
that target microglia in neuropathic pain states.
EXPERIMENTAL PROCEDURES
Details are further described in Supplemental Experimental Procedures.
Animals
Mice were bred and maintained at the EMBL Mouse Biology Unit, Montero-
tondo, in accordance with Italian legislation under license from the Italian Min-
istry of Health. The TMEM16F targeting strategy was designed to allow Cre-
mediated excision of the exons 13 of the TMEM16F, resulting in a frameshift
mutation in exon 14. The LysMCre line (Clausen et al., 1999) was used as a
driver line for conditional ablation of TMEM16F. CrosseswithRosa26tdRFP,Ro-
sa26Clsensor, and CX3CR1GFP mouse lines yielded reporters for visual and
functional tracking.
Pain Models and Behavioral Assays
Partial nerve ligation of the left sciatic nerve was performed on mice of both
sexes to induce neuropathic pain behavior as described previously (Seltzer
et al., 1990). Mice were tested blindly for mechanical allodynia using calibrated
von Frey filaments of increasing force applied to the hindpaw and fitting the
paw withdrawal probability. Inflammatory pain was induced by intraplantar in-
jection of Complete Freund’s Adjuvant (CFA). To trace central sensory end-
ings, 2-ml injections of 0.5% cholera Toxin-B (CTB) Alexa Fluor 647 conjugate
were performed into the sciatic nerve.
Double RNA Fluorescent In Situ Hybridization and
Immunofluorescence
In situ hybridization (ISH) was performed on spinal cord cryosections using a
fluorescein-labeled probe generated from a full-length TMEM16F cDNA.
Briefly, sections were fixed in 4% paraformaldehyde (PFA), digested with pro-
teinase K for 5 min, acetylated, and hybridized with the probes in 50% form-
amide, 5 3 saline sodium citrate (SSC), 5 3 Denhardt’s solution, 500 mg/ml
salmon sperm DNA, and 250 mg/ml tRNA overnight at 56C. After stringentCell Reports 15, 2608–2615, June 21, 2016 2613
post-hybridization washes, sections were blocked and incubated with mouse
anti-fluorescein (Roche; at 1:100) and rabbit anti-Iba1 (Wako; at 1:200), fol-
lowed by anti-mouse Alexa 555 and anti-rabbit Alexa 488.
Real-Time PCR
Homogenates of DRG, brain, kidney, L4–L6 segment of the lumbar spinal cord,
and lysates ofmicroglia cells were subjected to total RNA extraction and qPCR
according to standard protocol. Each mRNA expression level was normalized
to ubiquitin or GADPH.
Western Blotting
Harvested tissues were homogenized on ice in lysis buffer proteinase inhibitor.
10-mg lysates were loaded for gel electrophoresis. Western blot was per-
formed using standard techniques with rabbit anti-TMEM16F (HPA038958,
Sigma).
Immunohistochemistry
Immunohistochemistry was performed on paraformaldehyde-fixed cryosec-
tions and free floating sections according to standard protocols. The following
primary antibodies were incubated overnight at 4C: rabbit anti-Iba1 (019-
19741, Wako; 2.5 mg/ml), rat anti-CD68 (Abd Biotech; 10 mg/ml), mouse anti-
NeuN (1:250), rabbit anti-P2X4 receptor (ab82329, Abcam; 1:200), rabbit
anti-RFP (600-401-379, Rockland; 5 mg/ml), and rabbit anti-GABA (A2052,
Sigma;1:2,000). For co-staining with RFP or P2X4R or GABA, a mouse goat
anti-Iba1 (Novus; 5 mg/ml) was used. Anti-rabbit-, anti-rat, and anti-mouse
Alexa 488, 546, or 647 secondary antibodies (2 mg/ml) (Life Technologies)
were used. Z optical series covered 42 mm of thickness for free floating sec-
tions and 12 mm for cryosections with 0.5 mm step.
Time-Lapse Microscopy of Microglia
Time-lapse imaging of microglia in the culture and spinal cord slices was car-
ried out on a spinning-disk confocal ultraview Vox (Cellular imaging, Perki-
nElmer) at 37C and 5% CO2. For spinal cord, ex vivo time-lapse Z optical se-
ries covered 40 mm of thickness with 0.5 mm step. For phagocytosis assays,
primary microglia cells expressing endogenous ClSensor (Batti et al., 2013)
were co-incubated with fluorescent heat-killed S. cerevisiae yeast. Images
were taken every minute for 30 min.
Time-lapse imaging of microglial branch extension in hippocampal slice
from CX3CR1GFPmice was performed at room temperature during 2–7 hr after
cutting. Adenosine 50-triphosphate magnesium salt (ATP, 2 mM; Sigma-Al-
drich) was pressure applied (100 ms; 5 psi) from the glass pipette placed in
the stratum radiatum. GFP fluorescence was measured every 10 s for
50 min in a 20-mm diameter area around the pipette tip to quantify the speed
of GFP-expressing microglial processes extension.
Image Analysis
Three-dimensional reconstructions of confocal stacks and surface rendering
were performed with Imaris Bitplane Software (Bitplane). Surface, Filament,
and Spots Imaris modules were used for segmentation and tracking of micro-
glial cells, microglia processes, and neuron terminals, respectively. Tracking
analysis of single microglial processes in the hippocampal slice was per-
formed using ImageJ software.
Cytokine Arrays
Protein extracts from sciatic nerve fragments were processed with pre-
spotted cytokine/chemokine array according to manufacturer’s instructions
(R&D Systems, mouse cytokine array panel A, no. ARY006). Signal intensity
was analyzed in ImageJ, background subtracted, and averaged on duplicates
and between three sets of four mice.
Statistical Analysis
Statistical significance was determined as p < 0.05 by one-way ANOVA (Fig-
ures 2A, 3D, 3F, 3G, and 4C) or two-way ANOVA test (Figures 1A, 2B–2D,
3B, 3C, and 4B) followed by Bonferroni post hoc test, Student’s t test (Fig-
ure 4A), c2 test, or Mann Whitney test (Figures 2F and 2G).2614 Cell Reports 15, 2608–2615, June 21, 2016SUPPLEMENTAL INFORMATION
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